{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:54:39Z","timestamp":1792760079702,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejps.2024.106970","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T08:07:11Z","timestamp":1732176431000},"page":"106970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Population pharmacokinetic analysis in children with different diseases treated with mycophenolate mofetil\u2014Integrated analysis of clinical trials and real-world clinical data"],"prefix":"10.1016","volume":"204","author":[{"given":"Jumpei","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimasa","family":"Yamatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Akabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Sako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejps.2024.106970_bib0001","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2125.2012.04213.x","article-title":"Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children","volume":"74","author":"Barau","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2024.106970_bib0002","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.ejps.2024.106970_bib0003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12016-023-08963-3","article-title":"Perspectives on mycophenolate mofetil in the management of autoimmunity","volume":"65","author":"Bhat","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.ejps.2024.106970_bib0004","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.ftd.0000167885.17280.6f","article-title":"Determinants of mycophenolic acid levels after renal transplantation","volume":"27","author":"Borrows","year":"2005","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.ejps.2024.106970_bib0005","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ejps.2024.106970_bib0006","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00228-022-03435-7","article-title":"The effect of concomitant use of proton pump inhibitors with CDK 4\/6 inhibitors on survival in metastatic breast cancer","volume":"79","author":"\u00c7a\u011flayan","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejps.2024.106970_bib0007","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/j.1600-6143.2005.01107.x","article-title":"Influence of co-medication with sirolimus or cyclosporine on mycophenolic acid pharmacokinetics in kidney transplantation","volume":"5","author":"Cattaneo","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.ejps.2024.106970_bib0008","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.2005.02398.x","article-title":"Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling","volume":"60","author":"Cremers","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2024.106970_bib0009","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/FTD.0b013e3181efd715","article-title":"Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease","volume":"32","author":"de Winter","year":"2010","journal-title":"Ther. Drug Monit."},{"issue":"3","key":"10.1016\/j.ejps.2024.106970_bib0010","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2215\/CJN.05440610","article-title":"Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: implications for therapeutic drug monitoring","volume":"6","author":"de Winter","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.ejps.2024.106970_bib0011","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1016\/j.transproceed.2010.09.047","article-title":"Proton pump inhibitor co-medication reduces active drug exposure in heart transplant recipients receiving mycophenolate mofetil","volume":"42","author":"Doesch","year":"2010","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.ejps.2024.106970_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2133\/dmpk.DMPK-13-RV-112","article-title":"Optimization of mycophenolic acid therapy using clinical pharmacometrics","volume":"29","author":"Dong","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"10","key":"10.1016\/j.ejps.2024.106970_bib0013","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s10157-022-02233-w","article-title":"Use of mycophenolate mofetil in patients with pediatric and adult primary nephrotic syndrome: information from a Japanese hospital claims database","volume":"26","author":"Funatogawa","year":"2022","journal-title":"Clin. Exp. Nephrol."},{"issue":"7\u20138","key":"10.1016\/j.ejps.2024.106970_bib0014","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1345\/aph.1R071","article-title":"Evaluation of potential interactions between mycophenolic acid derivatives and proton pump inhibitors","volume":"46","author":"Gabardi","year":"2012","journal-title":"Ann. Pharmacother"},{"issue":"4","key":"10.1016\/j.ejps.2024.106970_bib0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10157-018-1529-7","article-title":"Validation of estimated glomerular filtration rate equations for Japanese children","volume":"22","author":"Gotoh","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"issue":"5","key":"10.1016\/j.ejps.2024.106970_bib0016","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1046\/j.1600-6143.2005.00779.x","article-title":"Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2","volume":"5","author":"Hesselink","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.ejps.2024.106970_bib0017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/FTD.0b013e318074d979","article-title":"Prediction of unbound mycophenolic acid concentrations in patients after hematopoietic cell transplantation","volume":"29","author":"Huang","year":"2007","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.ejps.2024.106970_bib0018","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1681\/ASN.2021050643","article-title":"Mycophenolate mofetil after rituximab for childhood-onset complicated frequently-relapsing or steroid-dependent nephrotic syndrome","volume":"33","author":"Iijima","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"issue":"15","key":"10.1016\/j.ejps.2024.106970_bib0019","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2217\/pgs-2021-0087","article-title":"Effect of UGT polymorphisms on pharmacokinetics and adverse reactions of mycophenolic acid in kidney transplant patients","volume":"22","author":"Jiang","year":"2021","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.ejps.2024.106970_bib0020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0009-9236(98)90102-3","article-title":"The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function","volume":"63","author":"Johnson","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejps.2024.106970_bib0021","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/FTD.0b013e318206a1b1","article-title":"The role of proton pump inhibitors on early mycophenolic acid exposure in kidney transplantation: evidence from the CLEAR study","volume":"33","author":"Kiberd","year":"2011","journal-title":"Ther. Drug Monit."},{"issue":"11","key":"10.1016\/j.ejps.2024.106970_bib0022","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/0091270011422814","article-title":"Population pharmacokinetics of unbound mycophenolic acid in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantation","volume":"52","author":"Kim","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejps.2024.106970_bib0023","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.healun.2009.03.006","article-title":"Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients","volume":"28","author":"Kofler","year":"2009","journal-title":"J. Heart Lung Transplant."},{"issue":"6","key":"10.1016\/j.ejps.2024.106970_bib0024","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/S0041-1345(03)00762-0","article-title":"The influence of calcineurin inhibitors on mycophenolic acid pharmacokinetics","volume":"35","author":"Kuriata-Kordek","year":"2003","journal-title":"Transplant. Proc."},{"issue":"2","key":"10.1016\/j.ejps.2024.106970_bib0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2215\/CJN.07111009","article-title":"Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation","volume":"5","author":"Kuypers","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.ejps.2024.106970_bib0026","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.clpt.2005.06.007","article-title":"The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients","volume":"78","author":"Kuypers","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ejps.2024.106970_bib0027","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jcph.14","article-title":"Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil","volume":"53","author":"Li","year":"2013","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2024.106970_bib0028","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00228-021-03265-z","article-title":"Population pharmacokinetic and dose optimization of mycophenolic acid in children with anti-neutrophilic cytoplasmic antibody-associated nephritis","volume":"78","author":"Li","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejps.2024.106970_bib0029","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/lt.21274","article-title":"Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine","volume":"13","author":"Lobritto","year":"2007","journal-title":"Liver. Transpl."},{"issue":"5","key":"10.1016\/j.ejps.2024.106970_bib0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007890-200003150-00035","article-title":"Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506\/MMF Dose-Ranging Kidney Transplant Study Group","volume":"69","author":"Miller","year":"2000","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ejps.2024.106970_bib0031","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/FTD.0b013e31816337b7","article-title":"Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation","volume":"30","author":"Miura","year":"2008","journal-title":"Ther. Drug Monit."},{"issue":"12","key":"10.1016\/j.ejps.2024.106970_bib0032","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00228-007-0380-7","article-title":"Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients","volume":"63","author":"Miura","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2024.106970_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40780-022-00271-w","article-title":"Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis","volume":"9","author":"Mizaki","year":"2023","journal-title":"J. Pharm. Health Care Sci."},{"issue":"12","key":"10.1016\/j.ejps.2024.106970_bib0034","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1177\/0091270011423661","article-title":"A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic acid and tacrolimus early after renal transplantation","volume":"52","author":"Musuamba","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejps.2024.106970_bib0035","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10157-013-0799-3","article-title":"Creatinine-based equations to estimate glomerular filtration rate in Japanese children aged between 2 and 11 years old with chronic kidney disease","volume":"17","author":"Nagai","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"issue":"13","key":"10.1016\/j.ejps.2024.106970_bib0036","doi-asserted-by":"crossref","first-page":"e6469","DOI":"10.1097\/MD.0000000000006469","article-title":"Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: cross-sectional study","volume":"96","author":"Noreikait\u0117","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ejps.2024.106970_bib0037","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FTD.0b013e3180318c35","article-title":"Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus","volume":"29","author":"Patel","year":"2007","journal-title":"Ther. Drug Monit."},{"issue":"3","key":"10.1016\/j.ejps.2024.106970_bib0038","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/01.ftd.0000159784.25872.f6","article-title":"Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients","volume":"27","author":"Payen","year":"2005","journal-title":"Ther. Drug Monit."},{"issue":"9","key":"10.1016\/j.ejps.2024.106970_bib0039","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s11095-009-9931-1","article-title":"Semiparametric distributions with estimated shape parameters","volume":"26","author":"Petersson","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106970_bib0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.ftd.0000162231.90811.38","article-title":"Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods","volume":"27","author":"Pr\u00e9maud","year":"2005","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.ejps.2024.106970_bib0041","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.phrs.2009.09.006","article-title":"Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipients","volume":"61","author":"Pr\u00e9maud","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejps.2024.106970_bib0042","unstructured":"Roche Laboratories Inc, Cellcept product information, 2023. https:\/\/assets.roche.com\/f\/173850\/x\/54df9ba719\/cellcept_pm_e.pdf. Accessed online 04.04.2024."},{"issue":"4","key":"10.1016\/j.ejps.2024.106970_bib0043","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/bcp.14590","article-title":"Population pharmacokinetics of mycophenolic acid in paediatric patients","volume":"87","author":"Rong","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2024.106970_bib0044","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.phrs.2011.01.009","article-title":"Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome","volume":"63","author":"Saint-Marcoux","year":"2011","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.ejps.2024.106970_bib0045","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/FTD.0000000000000947","article-title":"Drug-drug interactions between mycophenolic acid and proton pump inhibitors: a systematic review and meta-analysis","volume":"44","author":"Sakuludomkan","year":"2022","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.ejps.2024.106970_bib0046","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.transproceed.2009.05.015","article-title":"Inadequate mycophenolic acid exposure and acute rejection in kidney transplantation","volume":"41","author":"S\u00e1nchez-Fructuoso","year":"2009","journal-title":"Transplant. Proc."},{"issue":"5","key":"10.1016\/j.ejps.2024.106970_bib0047","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10928-007-9066-0","article-title":"Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies","volume":"34","author":"Savic","year":"2007","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"5","key":"10.1016\/j.ejps.2024.106970_bib0048","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1034\/j.1600-6143.2003.00079.x","article-title":"Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies","volume":"3","author":"Shaw","year":"2003","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.ejps.2024.106970_bib0049","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2125.2011.04140.x","article-title":"Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus","volume":"73","author":"Sherwin","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2024.106970_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200107150-00014","article-title":"Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients","volume":"72","author":"Squifflet","year":"2001","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ejps.2024.106970_bib0051","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.ejps.2024.106970_bib0052","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/ndt\/gfaa111","article-title":"Effect of the proton-pump Inhibitor pantoprazole on MycoPhenolic ACid exposure in kidney and liver transplant recipienTs (IMPACT study): a randomized trial","volume":"35","author":"Sunderland","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.ejps.2024.106970_bib0053","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/lt.23679","article-title":"Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation","volume":"19","author":"Takada","year":"2013","journal-title":"Liver. Transpl."},{"issue":"2","key":"10.1016\/j.ejps.2024.106970_bib0054","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10157-017-1460-3","article-title":"Creatinine-based estimated glomerular filtration rate for children younger than 2 years","volume":"22","author":"Uemura","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"issue":"4","key":"10.1016\/j.ejps.2024.106970_bib0055","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s10157-013-0856-y","article-title":"Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease","volume":"18","author":"Uemura","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"issue":"5","key":"10.1016\/j.ejps.2024.106970_bib0056","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/TP.0b013e3181ca7d84","article-title":"Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid","volume":"89","author":"van Gelder","year":"2010","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.ejps.2024.106970_bib0057","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2165\/00003088-200544100-00006","article-title":"Population pharmacokinetics of mycophenolic acid in renal transplant recipients","volume":"44","author":"van Hest","year":"2005","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.ejps.2024.106970_bib0058","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/acs.molpharmaceut.1c00792","article-title":"In vitro predictive dissolution test should be developed and recommended as a bioequivalence standard for the immediate-release solid oral dosage forms of the highly variable mycophenolate mofetil","volume":"19","author":"Wang","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2024.106970_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1002628","article-title":"Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2024.106970_bib0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/dmd.105.006122","article-title":"Role of Mrp2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect of cyclosporine","volume":"34","author":"Westley","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.ejps.2024.106970_bib0061","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bcp.12392","article-title":"Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring","volume":"78","author":"Woillard","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2024.106970_bib0062","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/bmt.2017.213","article-title":"Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation","volume":"53","author":"Yoshimura","year":"2018","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.ejps.2024.106970_bib0063","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2125.2010.03734.x","article-title":"Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation","volume":"70","author":"Zeng","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2024.106970_bib0064","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2125.2010.03615.x","article-title":"Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome","volume":"69","author":"Zhao","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejps.2024.106970_bib0065","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/clpt.2009.210","article-title":"Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients","volume":"86","author":"Zhao","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.ejps.2024.106970_bib0066","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1177\/0091270009357429","article-title":"Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients","volume":"50","author":"Zhao","year":"2010","journal-title":"J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724002835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724002835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:37:58Z","timestamp":1738438678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724002835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":66,"alternative-id":["S0928098724002835"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106970","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetic analysis in children with different diseases treated with mycophenolate mofetil\u2014Integrated analysis of clinical trials and real-world clinical data","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106970"}}